Longitudinal Assessment Reveals Cost-Effectiveness of Erenumab for Treatment of Migraine AJMC, 16 Nov 2019 A longitudinal assessment of the cost-effectiveness of erenumab as a treatment for migraine exhibited higher patient utility…